Cardiac-resynchronization therapy for mild-to-moderate heart failure.
暂无分享,去创建一个
John L Sapp | Graham Nichol | George A Wells | J. Healey | S. Connolly | S. Hohnloser | J. Rouleau | G. Nichol | R. Yee | G. Wells | M. Talajic | D. Birnie | J. Sapp | R. Sheldon | Raymond Yee | Mario Talajic | A. Tang | M. Arnold | Stefan H Hohnloser | Jean L Rouleau | David H Birnie | Stuart Connolly | Anthony S L Tang | Robert Sheldon | Malcolm O Arnold | Jeffrey S Healey
[1] J. Daubert,et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. , 2005, The New England journal of medicine.
[2] Stefano Ghio,et al. Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. , 2008, Journal of the American College of Cardiology.
[3] J. Oss,et al. PROPHYLACTIC IMPLANTATION OF A DEFIBRILLATOR IN PATIENTS WITH MYOCARDIAL INFARCTION AND REDUCED EJECTION FRACTION , 2002 .
[4] Wojciech Zareba,et al. Cardiac-resynchronization therapy for the prevention of heart-failure events. , 2009, The New England journal of medicine.
[5] C. Israel,et al. Complications leading to surgical revision in implantable cardioverter defibrillator patients: comparison of patients with single-chamber, dual-chamber, and biventricular devices. , 2009, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[6] J. Daubert,et al. Safety of transvenous cardiac resynchronization system implantation in patients with chronic heart failure: combined results of over 2,000 patients from a multicenter study program. , 2005, Journal of the American College of Cardiology.
[7] D G Altman,et al. Calculating the number needed to treat for trials where the outcome is time to an event , 1999, BMJ.
[8] Douglas L Packer,et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. , 2005, The New England journal of medicine.
[9] William T. Abraham,et al. Focused Update : ACCF / AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults , 2013 .
[10] Claudia Stöllberger,et al. Guidelines for device-based therapy of cardiac rhythm abnormalities. , 2009, Heart rhythm.
[11] Stefan Sack,et al. Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. , 2002, Journal of the American College of Cardiology.
[12] J. Ornato,et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult—Summary Article , 2005 .
[13] F. Gaita,et al. Functional and echocardiographic improvement following multisite biventricular pacing for congestive heart failure. , 2003, Canadian Journal of Cardiology.
[14] R. McKelvie,et al. Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006: diagnosis and management. , 2006, The Canadian journal of cardiology.
[15] David L Hayes,et al. Sustained Reverse Left Ventricular Structural Remodeling With Cardiac Resynchronization at One Year Is a Function of Etiology: Quantitative Doppler Echocardiographic Evidence From the Multicenter InSync Randomized Clinical Evaluation (MIRACLE) , 2006, Circulation.
[16] Jeroen J. Bax,et al. Mechanism of improvement in mitral regurgitation after cardiac resynchronization therapy. , 2008, European heart journal.
[17] E. Foster,et al. Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias. , 2003, Journal of the American College of Cardiology.
[18] E. Fallen,et al. Effect of Cardiac Resynchronization on Myocardial Efficiency and Regional Oxidative Metabolism , 2003, Circulation.
[19] Harlan M Krumholz,et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemaker , 2008, Journal of the American College of Cardiology.
[20] W. Braham,et al. Cardiac Resynchronization in Chronic Heart Failure , 2002 .
[21] S. Connolly,et al. Resynchronization/defibrillation for ambulatory heart failure trial: rationale and trial design , 2009, Current opinion in cardiology.
[22] Milton Packer,et al. Cardiac resynchronization in chronic heart failure. , 2002, The New England journal of medicine.
[23] R. Canby,et al. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. , 2003, JAMA.
[24] Gregory S. Nelson,et al. Left Ventricular or Biventricular Pacing Improves Cardiac Function at Diminished Energy Cost in Patients With Dilated Cardiomyopathy and Left Bundle-Branch Block , 2000, Circulation.
[25] J. Daubert,et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. , 2001, The New England journal of medicine.
[26] Harlan M Krumholz,et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemaker , 2008, Circulation.
[27] D. DeMets,et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. , 2004, The New England journal of medicine.